EnglishFrenchGermanItalianPortugueseRussianSpanish

EMVO Onboarding & EU Falsified Medicines Directive

EMVO Onboarding & EU Falsified Medicines Directive: 

What to Know and Where to Begin

Presented by:

Fanny Trenteseaux Project Coordinator/Customer Relation Manager

European Medicines Verification Organisation  &

Mark Davison Senior Operations Director for rfxcel

Thursday, March 29, 2018

16.00 BST / 17.00 CEST / 11:00 AM EDT

 

Register here

 

Please join us for a webinar explaining the EMVO Onboarding Process and the Falsified Medicines Directive requirements; co-presented by Fanny Trenteseaux of the European Medicines Verification Organisation (EMVO) and Mark Davison of rfxcel. On this hour-long call, we will provide:

  1. A brief introduction to the EU Falsified Medicines Directive/Delegated Regulation
  2. Explanation of the EMVO and how to onboard your organization
  3. How to choose a gateway provider (IT partner)
  4. Q&A – plenty of time to get your specific queries answered

 

About Our Speakers:

Fanny Trenteseaux, a member of EMVO’s Commercial & Partner Management team, is a Project Coordinator and Customer Relation, Manager. She is actively assisting with the contractual on-boarding process, manages the Legitimacy Check process, and manages the Community of National Medicines Verification Organisations.

Mark Davison, Senior Operations Director for Europe at rfxcel, is a leading traceability and digital health expert as well as the published author of “Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs”. Mark specializes in global health and big data issues such as serialisation, supply chain security, patient safety and government policy.

 

EMVO Onboarding rfxcel
EMVO Onboarding rfxcel